Nutranomics Inc (NNRX)

[OTCRIDER]

Cancer Research
Tempus in the news

October 4, 2018

Tempus and Mary Crowley Cancer Research Launch a New Lung Cancer Initiative


October 4 – Tempus, a leading technology company advancing precision medicine through the collection and analysis of molecular and clinical data and Mary Crowley Cancer Research have announced a new collaboration with the objective of expanding research options for lung cancer patients. As part of this collaboration, Tempus...

August 30, 2018

Groupon Cofounder’s Health Startup Hits $2 Billion Valuation With Latest Funding Round


Tempus, a startup using data analytics to improve cancer treatment, raised $110 million in its Series E financing, the company announced Wednesday. Its third fundraise in 11 months, this round brings the company’s valuation to about $2 billion. To date Tempus has raised $320 million since it was founded by GrouponGRPN -0.33% co...
https://www.tempus.com/news/